The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion
T Barbui, J Thiele, H Gisslinger, HM Kvasnicka… - Blood cancer …, 2018 - nature.com
The new edition of the 2016 World Health Organization (WHO) classification system for
tumors of the hematopoietic and lymphoid tissues was published in September 2017. Under …
tumors of the hematopoietic and lymphoid tissues was published in September 2017. Under …
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Abstract The World Health Organization (WHO) classification of tumors of the hematopoietic
and lymphoid tissues was last updated in 2008. Since then, there have been numerous …
and lymphoid tissues was last updated in 2008. Since then, there have been numerous …
Myeloproliferative neoplasms, version 3.2022, NCCN clinical practice guidelines in oncology
AT Gerds, J Gotlib, H Ali, P Bose, A Dunbar… - Journal of the National …, 2022 - jnccn.org
The classic Philadelphia chromosome–negative myeloproliferative neoplasms (MPN)
consist of myelofibrosis, polycythemia vera, and essential thrombocythemia and are a …
consist of myelofibrosis, polycythemia vera, and essential thrombocythemia and are a …
Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis
A Tefferi, P Guglielmelli, DR Larson… - Blood, The Journal …, 2014 - ashpublications.org
Abstract Janus kinase 2 (JAK2) mutations define polycythemia vera (PV). Calreticulin
(CALR) and myeloproliferative leukemia virus oncogene (MPL) mutations are specific to …
(CALR) and myeloproliferative leukemia virus oncogene (MPL) mutations are specific to …
The international consensus classification of myeloid neoplasms and acute leukemias: myeloproliferative neoplasms
J Thiele, HM Kvasnicka, A Orazi… - American journal of …, 2023 - Wiley Online Library
A group of international experts, including hematopathologists, oncologists, and geneticists
were recently summoned (September 2021, Chicago, IL, USA) to update the 2016/17 World …
were recently summoned (September 2021, Chicago, IL, USA) to update the 2016/17 World …
Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms
Philadelphia-negative classical myeloproliferative neoplasms (MPNs) include polycythemia
vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF). The 2016 …
vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF). The 2016 …
Polycythemia vera and essential thrombocythemia: 2017 update on diagnosis, risk‐stratification, and management
Abstract Disease overview Polycythemia Vera (PV) and essential thrombocythemia (ET) are
myeloproliferative neoplasms respectively characterized by erythrocytosis and …
myeloproliferative neoplasms respectively characterized by erythrocytosis and …
Leukocytosis and thrombosis in essential thrombocythemia and polycythemia vera: a systematic review and meta-analysis
In the last years, a growing amount of evidence has been produced regarding the role of
leukocytosis as a risk factor for thrombosis in patients with myeloproliferative neoplasms …
leukocytosis as a risk factor for thrombosis in patients with myeloproliferative neoplasms …
Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk‐stratification and management
Disease overview: Polycythemia vera (PV) and essential thrombocythemia (ET) are
myeloproliferative neoplasms, respectively characterized by erythrocytosis and …
myeloproliferative neoplasms, respectively characterized by erythrocytosis and …
Myeloproliferative neoplasms: a decade of discoveries and treatment advances
A Tefferi - American journal of hematology, 2016 - Wiley Online Library
Myeloproliferative neoplasms (MPN) are clonal stem cell diseases, first conceptualized in
1951 by William Dameshek, and historically included chronic myeloid leukemia (CML) …
1951 by William Dameshek, and historically included chronic myeloid leukemia (CML) …